QUADRAMET 1.3 GBq/ml, solution for injection bottle
Active ingredients: Samarium-153, SAMARIUM [153 SM] LEXIDRONAM PENTASODIUM
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for injectionbottleintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- QUADRAMET 1,3 GBq/ml , solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre de 1,3 GBq/ml
- Marketing authorisation holder
- CIS BIO INTERNATIONAL
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Apr 1998
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68052014CIP75609869CIP133400956098699Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SAMARIUM [153 SM] LEXIDRONAM PENTASODIUMsolution | 1,3 GBq à la date de calibration · 1 ml | SA |
| SAMARIUM [153 SM]solution | 20 à 46 microgrammes · 1 ml | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.